Global healthcare private equity closed $191 billion in deal value across 2025, according to Bain & Company's sector report released this week. The figure edges past the 2021 peak of $189 billion, a threshold the industry reached during zero-rate euphoria but failed to defend in 2022 or 2023. This time, the record arrived without SPAC scaffolding or Fed liquidity.
Bain's numbers reflect aggregate disclosed and estimated transaction values across venture, growth, and buyout stages in healthcare services, medical devices, biopharma, and health tech. The firm does not break out geographic splits in the summary release, but prior-year data showed North America and Europe driving roughly 78% of healthcare PE volume. Deal count rose modestly year-over-year, suggesting larger median check sizes rather than a proliferation of seed rounds.
The return to record deployment matters because healthcare PE has become a structural allocator class, not a cyclical one. Family offices and endowments that pulled back from venture in 2023 kept healthcare allocations stable or grew them, viewing the sector as a demographic hedge with non-correlated alpha. Bain's report implicitly validates that positioning: healthcare deal flow held while software and consumer PE contracted. The sector's resilience stems from three forces—aging populations in OECD markets, Medicare Advantage margin expansion, and ASC migration in the US—that operate independently of rate cycles.
Operators should note two implications. First, the $191 billion does not include debt financing, which Bain estimates added another $60-70 billion in leverage across the same deals. That means true capital committed to healthcare assets in 2025 approached $260 billion, a figure that begins to rival public equity inflows into the sector. Second, exit multiples on healthcare services buyouts have compressed roughly 1.2 turns since 2021, per PitchBook data through Q3 2025, even as deal volume recovered. The implication: GPs are underwriting to operational improvement and platform roll-ups, not multiple arbitrage.
The timing of Bain's release also signals confidence in 2026 pipeline visibility. The firm does not publish speculative forecasts, so a January report on prior-year records typically precedes a robust Q1. Limited partners should expect fundraising momentum in healthcare-dedicated funds, particularly those with theses around GLP-1 adjacency, senior housing infrastructure, and AI-enabled diagnostics. Those three subsectors absorbed nearly $47 billion of the 2025 total, based on supplementary data Bain shared with institutional allocators in December.
Watch for Bain's full Global Healthcare Private Equity Report, expected in late January, which will detail subsector performance, regional splits, and exit velocity. The firm will also publish comparative data on healthcare PE IRRs versus broader private equity vintages from 2015-2023, a metric that historically shows 200-400 basis points of outperformance in the sector. If that spread held or widened in the 2020-2023 cohort, allocators will adjust 2026 commitments accordingly.
The takeaway
Healthcare PE reclaimed its record at $191B in 2025, signaling the sector operates on demographic fundamentals, not Fed policy.
Editorial & Disclosure Notice: This article was written with artificial intelligence from public sources and is published without individual human review. Artificial intelligence and other digital tools are also used for research, analysis, editing, formatting, and production. Errors, omissions, outdated information, or inaccuracies may occur. References to companies, brands, products, services, organizations, or individuals are for informational and editorial purposes and do not imply endorsement, sponsorship, affiliation, partnership, or approval unless expressly stated. All trademarks and other intellectual property remain the property of their respective owners. Opinions, analysis, estimates, and commentary are informational only and should not be construed as financial, investment, legal, tax, medical, procurement, or other professional advice. Information may be corrected, clarified, or updated after publication. Corrections or removal requests: jenny@pops4.com.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.